Business Context and Reporting Period
Company: BioCardia, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: May 15, 2026
Reporting Period: Quarter ended March 31, 2026
Business Context: The registrant is a Delaware corporation with principal executive offices in Sunnyvale, California. It trades on the Nasdaq Capital Market under the symbols BCDA (Common Stock) and BCDAW (Warrants).
Key Financial Metrics
The provided Form 8-K text serves as a notification of the release of financial results but does not contain the specific financial data itself. The actual metrics are located in the press release furnished as Exhibit 99.1, which is not included in the input text.
- Revenue: Not provided in filing text.
- Profit/Loss: Not provided in filing text.
- Cash Flow: Not provided in filing text.
- Margins: Not provided in filing text.
- Debt and Liquidity: Not provided in filing text.
Material Changes
The filing text does not provide specific comparative data or details regarding material changes versus the prior comparable period. It only confirms that results for the quarter ended March 31, 2026, were announced.
Guidance, Outlook, and Risks
Management Commentary: The filing references a press release issued on May 15, 2026, containing the results of operations and financial condition. No specific commentary, guidance, or outlook is detailed within the 8-K text itself.
Risks and Contingencies: The filing includes a standard disclaimer stating that the information in Item 2.02 and Exhibit 99.1 is "furnished" and not "filed" for purposes of Section 18 of the Exchange Act, nor is it incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated May 15, 2026) for actual revenue, net income, and cash flow figures.
- Verify the specific details of the "Results of Operations" mentioned in Item 2.02, as they are not embedded in the 8-K body.
- Check for any forward-looking statements or updated guidance contained within the referenced press release.
- Confirm the status of the Warrant (BCDAW) and Common Stock (BCDA) trading on the Nasdaq Capital Market.